Information Provided By:
Fly News Breaks for September 4, 2019
Sep 4, 2019 | 09:07 EDT
Northland analyst Suraj Kalia raised his price target on BioLife Solutions (BLFS) shares to $22 from $18 after the company announced that it had signed on Mustang Bio (MBIO) as a customer. He views the Mustang deal as validating the company's M&A strategy and has "an increasingly optimistic" outlook on the company's value proposition to biotech clients, stated Kalia, who keeps an Outperform rating on BioLife shares.
News For BLFS From the Last 2 Days
There are no results for your query BLFS